DrugPatentWatch Database Preview
Profile for China Patent: 103025330
US Patent Family Members and Approved Drugs for China Patent: 103025330
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Apr 11, 2023 | Celgene | REVLIMID | lenalidomide |
➤ Sign Up | Apr 11, 2023 | Celgene | REVLIMID | lenalidomide |
➤ Sign Up | Apr 11, 2023 | Celgene | REVLIMID | lenalidomide |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |